Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Hulot, Jean-Sébastien  [Clear All Filters]
2024
Sayed ZRAl, Pereira C, Le Borgne R, de Lesegno CViaris, Jouve C, Pénard E, Mallet A, Masurkar N, Loussouarn G, Verbavatz J-M, et al. CAVIN1-Mediated hERG Dynamics: A Novel Mechanism Underlying the Interindividual Variability in Drug-Induced Long QT. Circulation. 2024.
Seguret M, Davidson P, Robben S, Jouve C, Pereira C, Lelong Q, Deshayes L, Cerveau C, Le Berre M, Ribeiro RSRodrigue, et al. A versatile high-throughput assay based on 3D ring-shaped cardiac tissues generated from human induced pluripotent stem cell-derived cardiomyocytes. Elife. 2024;12.
2021
Fontaine V, Duboscq-Bidot L, Jouve C, Hamlin M, Curjol A, Briand V, Janiak P, Hulot J-S, Pruniaux-Harnist M-P, Charron P, et al. Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control. Stem Cell Res. 2021;52:102245.
de Boer RA, Heymans S, Backs J, Carrier L, Coats AJS, Dimmeler S, Eschenhagen T, Filippatos G, Gepstein L, Hulot J-S, et al. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: From molecular mechanisms to therapeutic targets. Eur J Heart Fail. 2021.
2019
Vermersch E, Jouve C, Hulot J-S. CRISPR/CAS9 Gene-Editing Strategies in Cardiovascular Cells. Cardiovasc Res. 2019.
Wu JC, Garg P, Yoshida Y, Yamanaka S, Gepstein L, Hulot J-S, Knollmann BC, Schwartz PJ. Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies. Circ Res. 2019;125(6):653-658.
2018
Hulot J-S, Vermersch E, Jouve C. CRISPRed Cardiomyocytes to Decrypt Variants of Uncertain Significance. J Am Coll Cardiol. 2018;72(1):76-78.
2013
Turnbull IC, Karakikes I, Serrao GW, Backeris P, Lee J-J, Xie C, Senyei G, Gordon RE, Li RA, Akar FG, et al. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J. 2013.
Karakikes I, Senyei GD, Hansen J, Kong C-W, Azeloglu EU, Stillitano F, Lieu DK, Wang J, Ren L, Hulot J-S, et al. Small Molecule-Mediated Directed Differentiation of Human Embryonic Stem Cells Toward Ventricular Cardiomyocytes. Stem Cells Transl Med. 2013.